As COVID-19 vaccine guidance shifts, new data suggest vaccinated patients face no greater clot or death risk than with other respiratory infections.
|Videos|October 21, 2019
Immunizations and Travel Health
Author(s)Total Pharmacy Team
Advertisement
Bruce Kneeland: How about immunizations, travel vaccines, those types of things?
Theresa Dickinson, RPh: We do immunizations, so we’ll do the flu shots for people. I guess some people pay for it, some people get their insurance to cover it, but either way people are coming to us for that.
Advertisement
Related to this article
Phase 2 trial results for the investigational vaccine were presented at IDWeek 2026 in Washington, DC, as the phase 3 program is currently underway.
New survey data add to the evidence regarding the safe and effective route of administering both COVID-19 and flu vaccines simultaneously.
Researchers provide an update on the adverse events of special interest following patients who received 2024–2025 Pfizer-BioNTech COVID-19 vaccination.
Researchers assessed the extent of which vaccine fatigue translates to reduced engagement and adherence among patients.
Advertisement
Advertisement
Trending on Drug Topics
1
COVID-19 Vaccine Lowers Venous Thromboembolism, Mortality Risk
2
PBMs Must Now Disclose Fees to Employer Plans Under Final DOL Rule
3
American Pharmacists Month: Pharmacists as Care Team Partners Fuels Optimism for the Profession
4
AI Prescribing Pilot Places Pharmacists as Final Link in Care
5